Dr. Ashish Sangal, MD

Dr. Sangal practices at Good Samaritan University Hospital in West Islip, New York, part of Diocese of Rockville Centre.

Dr. Sangal's NPI, 1043541576, was assigned on January 22, 2010. Dr. Sangal graduated from Coimbatore Medical College in 2000. Dr. Sangal holds New York license 307781.

Dr. Sangal's primary practice is Good Samaritan University Hospital, at 1000 Montauk Highway, West Islip, NY 11795 in Suffolk County. The practice phone is (631) 376-3000.

Dr. Sangal's primary practice is Good Samaritan University Hospital in West Islip, New York, part of Diocese of Rockville Centre. The medical group on file is Cardiac Interventional Group. Dmand AI also links Dr. Sangal to 1 more home health agency, 1 hospice and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sangal practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Sangal's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Sangal is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Sangal's licenses on file in 4 states: New York, Arizona, Maryland and Pennsylvania.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer and lymphoma among the conditions Dr. Sangal treats.

CMS data shows 1,964 Medicare services from Dr. Sangal across 10 procedure codes in 2024, for 511 Medicare patients. Medicare paid $158,162 for them.

CMS counts 511 Medicare patients who saw Dr. Sangal in 2024. The largest group is 75 to 84, with 204 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sangal's median patient age at 70, with 56% women.

In 2024, Dr. Sangal wrote 323 Medicare Part D claims for 89 patients. 49% of them were for generic drugs. CMS names the drug for 242 of them, across 7 drugs with 11 or more claims each, at $484,383 in total drug cost. In 2023, CMS named 184 claims across 8 drugs.

Dr. Sangal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 14 papers to Dr. Sangal, published from 2015 to 2025. 2017 was the busiest year, with 3. The most frequent topics are Neoplasm Metastasis, Adenocarcinoma and Palliative Care. Dr. Sangal has published most often in PLoS One. Dr. Sangal's most frequent co-authors are Johnny Kao, MD, Glen Weiss, MD and Symeon Missios, MD.

Dmand AI links Dr. Sangal to 10 clinical trials, 6 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Lung Neoplasms, Melanoma and Nevi and Melanomas. National Cancer Institute (NCI) sponsors the most, 7.

CMS Open Payments shows 200 general payments to Dr. Sangal from 61 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 60% of the total. AstraZeneca Pharmaceuticals LP paid the most, $9,691.

Dr. Sangal graduated from Coimbatore Medical College in 2000. Dr. Sangal is a member of ASCO, ASH and Arizona Medical Association.

Dr. Sangal is in network with 15 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.